The oncology platform provider, previously backed by Alphabet and LabCorp, has secured $175m in a round led by strategic partner Roche.

Pharmaceutical firm Roche led a $175m series C round yesterday for Flatiron Health, a US-based developer of cloud-based oncology software, as part of a newly formed strategic partnership.

Investment bank Allen & Company, investment management firm Baillie Gifford and investment firm Casdin Capital also participated in the round.

Flatiron has built a software platform called OncologyCloud that combines electronic medical records for oncology, an advanced analytics tool, a patient portal and a billing management system to help care providers treat…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?